Responses
Regular and young investigator award abstracts
Clinical trials in progress
412 First-in-human phase I/IIa trial to evaluate the safety and initial clinical activity of DuoBody®-PD-L1×4–1BB (GEN1046) in patients with advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.